Cargando…
Anti-Dlx5 Retards the Progression of Osteoarthritis through Inhibiting Chondrocyte Hypertrophy and Apoptosis
Osteoarthritis is a common degenerative joint disease that can cause pain and disability in patients. There is still a lack of effective treatments to improve pathological changes of osteoarthritis cartilages and reverse the progression of osteoarthritis. Our study aimed to investigate the role of D...
Autores principales: | Lu, Ye, Zhang, Chengyuan, Jiang, Shilin, Yuan, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906946/ https://www.ncbi.nlm.nih.gov/pubmed/35280506 http://dx.doi.org/10.1155/2022/5019920 |
Ejemplares similares
-
DLX5 promotes Col10a1 expression and chondrocyte hypertrophy and is involved in osteoarthritis progression
por: Chen, Jinnan, et al.
Publicado: (2023) -
Dlx5 Is a Cell Autonomous Regulator of Chondrocyte Hypertrophy in Mice and Functionally Substitutes for Dlx6 during Endochondral Ossification
por: Zhu, Hui, et al.
Publicado: (2009) -
The Role of Chondrocyte Hypertrophy and Senescence in Osteoarthritis Initiation and Progression
por: Rim, Yeri Alice, et al.
Publicado: (2020) -
BMP5 silencing inhibits chondrocyte senescence and apoptosis as well as osteoarthritis progression in mice
por: Shao, Yan, et al.
Publicado: (2021) -
miR-140 Attenuates the Progression of Early-Stage Osteoarthritis by Retarding Chondrocyte Senescence
por: Si, Hai-bo, et al.
Publicado: (2019)